JQUA:NYE-JPMorgan U.S. Quality Factor ETF (USD)

ETF | Others |

Last Closing

USD 31.65

Change

-0.46 (-1.43)%

Market Cap

USD 0.13B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-01-27 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

+0.04 (+0.21%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

-0.11 (-0.20%)

USD 32.78B
LCR Leuthold Core ETF

-0.09 (-0.27%)

USD 32.52B
DTB DTB

-0.12 (-0.63%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2..

-0.03 (-0.10%)

USD 26.11B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 22.47B
SGOV iShares® 0-3 Month Treasury B..

+0.03 (+0.03%)

USD 18.58B
TSPA T. Rowe Price US Equity Resear..

-0.07 (-0.22%)

USD 16.23B
DFUV Dimensional US Marketwide Valu..

+0.04 (+0.10%)

USD 10.15B
AVUV Avantis® U.S. Small Cap Value..

+0.02 (+0.02%)

USD 10.05B

ETFs Containing JQUA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.09% 68% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.09% 67% D+ 65% D
Trailing 12 Months  
Capital Gain 20.90% 78% C+ 77% C+
Dividend Return 0.92% 28% F 13% F
Total Return 21.82% 79% B- 75% C
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.66% 82% B 60% D-
Dividend Return 5.38% 83% B 48% F
Total Return 0.72% 48% F 17% F
Risk Return Profile  
Volatility (Standard Deviation) 7.39% 56% F 86% B+
Risk Adjusted Return 72.85% 88% B+ 73% C
Market Capitalization 0.13B 74% C 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.